July 2021
Therefore, they wrote, our findings may be explained by evidence suggesting that GLP-1RAs exert their effects, in part, by regulating several proinflammatory pathways. In summary, while this study suggests GLP-1 therapy for patients with type 2 diabetes may portend a reduced risk of incident AMD and slow progression of AMD, future research is needed to validate these findings, as well as investigate the drugs effect on AMD in non-diabetic patients
Easy things like consistent walks or quick at-home workouts complement retatrutide well
This helps keep blood vessels healthy and reduces the risk of developing cardiovascular diseases
How GLP-1 receptor agonists can promote weight loss GLP-1 receptor agonists mimic a natural hormone our intestines release called glucagon-like peptide 1, which can promote weight loss via three actions: Suppressing appetite "The drugs 'talk' to our brain to encourage us to eat less and to be less preoccupied with food," explains Alexandra Sowa, MD , a dual board-certified obesity and internal medicine physician practicing in New York City, a clinical instructor of medicine at New York University, and author of The Ozempic Revolution
